Log in

Sign up
JN

James Nelson

Director, Platform Development at Inanovate

Dr. Nelson is co-inventor of the Longitudinal Assay Screening technology. He leads the Bio-ID development. Dr. Nelson has over 16 years experience in developing and establishing advanced technologies for biomolecule screening, including 10 years as Manager of Technology Development at GlaxoSmithKline where he ran an interdisciplinary team on the development and optimization of next generation multiplexing technologies. Dr. Nelson holds a Bachelor of Science in Chemistry from the Florida State University and a Ph.D. in Organic Chemistry from the University of Illinois.

Org chart

View in org chart

AH

Aaron Harmon

General Manager & Director, Quality

GV

Greg Votaw

VP, Engineering

CW

Casey Wright

VP, Assay Development

Dale Guthrie

Operations, Engineering & Quality Manager

Avery Del Grosso

Director Of Clinical Integration

View in org chart

Timeline

  • Director, Platform Development

    Current role

A panel showing how The Org can help with contacting the right person.

Related people